Alaunos Therapeutics (TCRT) 10-K2012 FY Annual report

Filed: 18 Mar 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abstract, abuse, accessible, allegedly, Amello, andStock, apportioned, attorney, bacterial, bill, blinded, Carlo, category, CE, CEO, civil, clear, CMS, competitor, concealing, constitutionality, creatinine, creation, curtailment, cytopenia, database, death, decide, deep, defective, defraud, disfavor, dispensed, doubt, drawn, elevated, eleven, enterprise, entitledCertain, entitledIndependent, entitledStock, EU, false, falsifying, formulary, found, fourteen, fraud, fraudulent, fundraising, gap, gave, halt, highest, HIPAA, HITECH, IIRC, immunogenicity, implied, imprisonment, Indemnity, inter, interpret, interpreted, Jason, knowingly, largest, lawfully, licensure, mandatory, MATISSE, matter, Medicaid, modification, monotheraphy, MSc, narrowly, necessarily, neutropenia, newest, noncompliance, nondeductible, Novella, Obama, objective, outpatient, oversee, payer, payor, pharmacy, Portability, Poverty, PPACA, PR, PRA, preempted, prepayment, pressure, privacy, procurement, PSHA, put, pyrexia, QRE, quantity, radiologic, rare, rebate, Recovery, recurrent, referral, regional, reinstated, remuneration, repeal, SAE, scrutiny, sector, sixty, software, sophisticated, surrendered, sustaining, teaching, tier, topline, transmission, twenty, unapproved, unclear, underlying, uniform, unrelated, upheld, usage, user, vein, violate, violated, violation, Votrient®now, waiver, week, willfully, YERVOY

Removed: Bagley, carryforward, Caturano, CFR, Charlestown, coupled, creating, easier, expeditiously, Exploratory, expressing, facilitate, front, gathered, hopeful, indentified, limiting, original, principle, procedure, promise, propose, Richard, select, sublease, unnecessary, vehicle, wasteful, window, ZinaparTM

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

TCRT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Forms S-8 (File Nos. 333-129884, 333-134280, 333-142701, 333-160496 and 333-167925) and Forms S-3 (File Nos. 333-129680, 333-134279, 333-141014, 333-161453, 333-162160, 333-163517, 333-166444 and 333-174292) of ZIOPHARM Oncology, Inc. of our report dated March 18, 2013 relating to our audit of the financial statements and the effectiveness of internal control over financial reporting (which report includes an emphasis paragraph relating to an uncertainty as to the Company’s ability to continue as a going concern), which appears in this Annual Report on Form 10-K of ZIOPHARM Oncology, Inc. for the year ended December 31, 2012.

/s/ McGladrey LLP

Boston, Massachusetts

March 18, 2013